Механизмы взаимосвязи бронхиальной астмы и ожирения
https://doi.org/10.18093/0869-0189-2012-0-3-97-103
Аннотация
Механизмы взаимосвязи бронхиальной астмы и ожирения.
Об авторах
Л. Н. Приступа
Медицинский институт Сумского государственного университета
Россия
Россия
д. м. н., проф.., зав. кафедрой внутренней медицины последипломного образования с курсом пропедевтики
40007, Украина, г. Сумы, ул. Римского-Корсакова, 2. Тел./ факс: +38-0542-77-57-05.
А. А. Фадеева
Медицинский институт Сумского государственного университета
Россия
Россия
к. м. н., ассистент кафедры внутренней медицины последипломного образования с курсом пропедевтики
40007, Украина, г. Сумы, ул. Римского-Корсакова, 2. Тел./ факс: +38-0542-77-57-05.
Список литературы
1. Приступа Л.Н. Бронхіальна астма та метаболічний синдром: обґрунтування патогенетичних підходів до діагностики, лікування та профілактики: Автореф. дис. … д-ра мед. наук. Київ; 2006.
2. Vortmann M., Eisner M.D. BMI and health status among adults with asthma. Obesity 2008; 16 (1): 146–152.
3. Guerra S., Sherrill D. L., Bobadilla A. et al. The relation of body mass index to asthma, chronic bronchitis, and emphysema. Chest 2002; 122: 1256–1263.
4. Nystad W., Meyer H.E., Nafstad P. et al. Body mass index in relation to adult asthma among 135,000 Norwegian men and women. Am. J. Epidemiol. 2004; 160: 969–976
5. Ford E.S., Mannino D.M., Redd S.C. et al. Body mass index and asthma incidence among USA adults. Eur. Respir. J. 2004; 24: 740–744.
6. Beuther D.A., Weiss S.T., Sutherland E.R. Obesity and asthma. Am. J. Respir. Crit. Care Med. 2006; 174 (2): 112–119.
7. Фадєєва Г.А. Клініко-патогенетичне обґрунтування модифікації лікування хворих на бронхіальну астму, асоційовану з вісцеральним ожирінням: Автореф. дис. … канд. мед. наук. Київ; 2010.
8. Von Mutius E., Schwartz J., Neas L.M. et al. Relation of body mass index to asthma and atopy in children: the National Health and Nutrition Examination Study III. Thorax 2001; 56: 835–838.
9. Hancox R.J., Milne B.J., Poulton R. et al. Sex differences in the relation between body mass index and asthma and atopy in a birth cohort. Am. J. Respir. Crit. Care Med. 2005; 171: 440–445.
10. Nilsson M. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. J.A.M.A. 2003; 290 (1): 66–72.
11. Царев В.П. Клинико-иммунологические особенности течения бронхиальной астмы больных с избыточной массой тела. Иммунопатол., аллергол., инфектол. 2002; 2: 78–85.
12. Tantisira K.G., Litonjua A.A., Weiss S.T. et al. Association of body mass with pulmonary function in the Childhood Asthma Management Program (CAMP). Thorax 2003; 58: 1036–1041.
13. Hakala K., Stenius'Aarniala B., Sovijarvi A. Effects of weight loss on peak flow variability, airways obstruction, and lung volumes in obese patients with asthma. Chest 2000; 118: 1315–1321.
14. Litonjua A.A., Sparrow D., Celedon J.C. et al. Association of body mass index with the development of methacholine airway hyperresponsiveness in men: the Normative Aging Study. Thorax 2002; 57: 581–585.
15. Aaron S.D., Fergusson D., Dent R. et al. Effect of weight reduction on respiratory function and airway reactivity in obese women. Chest 2004; 125: 2046–2052.
16. Кетлинский С.А., Симбирцев А.С. Цитокины. СПб.: Фолиант; 2008.
17. Halasz A., Cserhati E., Cseh K. Role of the TNF system in the pathomechanism of bronchial asthma. Orv. Hetil. 2002; 143 (11): 553–557.
18. Holgate S.T., Peters'Golden M., Henderson W.R. et al. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J. Allergy Clin. Immunol. 2003; 111 (1): 18–34.
19. Tanaka S., Isoda F., Ishihara V. et al. T lymphopaenia in relation to body mass index and TNF-alpha in human obesity: adequate weight reduction can be corrective. Clin. Endocrinol. 2001; 54 (3): 347–354.
20. Visness C.M., London S.J., Daniels J.L. et al. Association of obesity with IgE levels and allergy symptoms in children and adolescents: results from the National Health and Nutrition Examination Survey 2005–2006. J. Allergy Clin. Immunol. 2009; 123 (5): 1163–1169.
21. Vieira V.J., Ronan A.M., Windt M.R. et al. Elevated atopy in healthy obese women1, 2, 3, 4, 5. Am. J. Clin. Nutr. 2005; 82 (3): 504–509.
22. Hernandes R.A., Matta C.J., Mora N.A. et al. Clinical symptom relief in obese patients with persistent moderate asthma secondary to decreased obesity. Rev. Alerg. Mex. 2008; 55 (3): 103–111.
23. Van Dielen F.M., van't Veer C., Schols A.M. et al. Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int. J. Obes. Relat. Metab. Disord. 2001; 25 (12): 1759–1766.
24. Bullo M., Pilar Garcia'Lorda, Megias I. et al. Systemic inflammation, adipose tissue necrosis factor, and leptin expression. Obes. Res. 2003; 11: 525–531.
25. Bastard J.P., Maachi M., Lagathu C. et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cyt. Netw. 2006; 17 (1): 4–12.
26. Weisberg S.P., McCann D., Desai M. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003; 112: 1796–1808.
27. Zumbach M.S., Boehme M.W., Wohl P. et al. Tumor necrosis factor increases serum leptin levels in humans. J. Clin. Endocrinol. 1997; 82 (12): 4080–4082.
28. Castro J., Telleria J.J., Linares P. et al. Increased TNFA-2, but not TNFB-1, allele frequency in Spanish atopic patients. J. Invest. Allergol. Clin. Immunol. 2000; 10 (3): 149–154.
29. Otero M., Lago R., Lago F. et al. Leptin, from fat to inflammation: old questions and new insights. FEBS Lett. 2005; 579 (2): 295–301.
30. Бабаджанова Г.Ю., Нагорный А.Б., Лебедин Ю.С., Чуча'лин А.Г. Содержание лептина у больных бронхиальной астмой и сахарным диабетом. Тер. арх. 2003; 3: 18–20.
31. Pilcova R., Sulcova J., Hill M. et al. Leptin levels in obese children: effects of gender, weight reduction and androgens. Physiol. Res. 2003; 52 (1): 53–60.
32. Heuck C., Wolthers O. D. Serum leptin in children with asthma treated with inhaled budesonide. Respir. Med. 1999; 93 (4): 268–271.
33. Zarkesh'Esfahani H., Pockley G., Metcalfe R.A. et al. Highdose leptin activates human leukocytes via receptor expression on monocytes. J. Immunol. 2001; 167: 4593–4599.
34. Martin'Romero C., Santos'Alvarez J., Goberna R. et al. Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell. Immunol. 2000; 199 (1): 15–24.
35. Caldefie'Chezet F., Poulin A., Tridon A. et al. Leptin: a potential regulator of polymorphonuclear neutrophil bactericidal action? J. Leuk. Biol. 2001; 69: 414–418.
36. Mattioli B., Straface E., Quaranta M.G. et al. Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming. J. Immunol. 2005; 174 (11): 6820–6828.
37. Shore S.A., Schwartzman I.N., Mellema M.S. et al. Effect of leptin on allergic airway responses in mice. J. Allergy Clin. Immunol. 2005; 115: 103–109.
38. Johnston R. A., Zhu M., Rivera'Sanchez Y.M et al. Allergic airway responses in obese mice. Am. J. Respir. Crit. Care Med. 2007; 176: 650–658.
39. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 2005; 115: 911–919.
40. Hersoug L.G., Linneberg A. The link between the epidemics of obesity and allergic diseases: does obesity induce decreased immune tolerance? Allergy 2007; 62 (10): 1205–1213.
41. Mascitelli L., Pezzetta F., Goldstein M.R. Leptin and regulatory T cells in obese patients with asthma. Thorax 2008; 63 (7): 659.
42. De Rosa V., Procaccini C., Cali G. et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity 2007; 26 (2): 241–255.
43. Tang C.'H., Lu D., Yang R. et al. Leptin-induced IL-6 production is mediated by leptin receptor, insulin receptor substrate-1, phosphatidylinositol 3-kinase, akt, NF-KB, and p300 pathway in microglia. J. Immunol. 2007; 179: 1292–1302.
44. Lappas M., Permezel M., Rice G.E. Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-KB, peroxisomal proliferator-activated receptor-γ and extracellularly regulated kinase 1/2. Endocrinology 2005; 146 (8): 3334–3342.
45. Lee G.H., Proenca R., Montez J.M. et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379: 632–635.
46. Wong C.K., Cheung P.F., Lam C.W. Leptin-mediated cytokine release and migration of eosinophils: implications for immunopathophysiology of allergic inflammation. Eur. J. Immunol. 2007; 37 (8): 2337–2348.
47. Mancuso P., Canetti C., Gottschalk A. et al. Leptin augments alveolar macrophage leukotriene synthesis by increasing phospholipase activity and enhancing group IVC iPLA2 (cPLA2gamma) protein expression. Am. J. Physiol. Lung Cell Mol. Physiol. 2004; 287 (3): 497–502.
48. D`Urso A. D., Chapman K. R. Leukotriene-receptor antagonists. Can. Fam. Physician 2000; 46: 872–879.
49. Peters'Golden M., Henderson W.R. Leukotrienes. N. Engl. J. Med. 2007; 357 (18): 1841–1854.
50. Woszczek G., Chen L.Y., Magineni S. et al. IL-10 inhibits cysteinyl leukotriene-induced activation of human monocytes and monocyte-derived dendritic cells. J. Immunol. 2008; 180 (11): 7597–7603.
51. Водолажський М.Л. Лейкотрієни крові дітей, хворих на бронхіальну астму, на фоні сучасної терапії: Автореф. дис. … канд. мед. наук. Харків; 2005.
52. DiMeo D., Tian J., Zhang J. et al. Increased interleukin-10 production and Th2 skewing in the absence of 5-lipoxygenase. Immunology 2008; 123 (2): 250–262.
53. Misso N.L., Petrovic N., Grove C. et al. Plasma phospholipase A2 activity in patients with asthma: association with body mass index and cholesterol concentration. Thorax 2008; 63 (1): 21–26.
54. Skalicky J., Muzakova V., Kandar R. et al. Evaluation of oxidative stress and inflammation in obese adults with metabolic syndrome. Clin. Chem. Lab. Med. 2008; 46 (4): 499–505.
55. Kimata H. Elevated serum leptin in AEDS. Allergy 2002; 57: 179–184.
56. Mai X.M., Bottcher M.F., Leijon I. Leptin and asthma in overweight children at 12 years of age. Pediatr. Allergy Immunol. 2004; 15 (6): 523–530.
57. Hukshorn C.J., Lindeman Jan H.N., Toet K.H. et al. Leptin and the proinflammatory state associated with human obesity. J. Clin. Endocrinol. 2004; 89 (4): 1773–1778.
58. Manigrasso M.R., Ferroni P., Santilli F. et al. Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. J. Clin. Endocrinol. 2005; 90 (10): 5876–5879.
59. Heilbronn L.K., Noakes M., Clifton P.M. Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler. Thromb. Vasc. Biol. 2001; 21 (6): 968–970.
60. Jung S., Park H., Kim K. Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss. J. Nutr. Biochem. 2008; 19 (6): 371–375.
Рецензия
Для цитирования:
Приступа Л.Н., Фадеева А.А. Механизмы взаимосвязи бронхиальной астмы и ожирения. Пульмонология. 2012;(3):97-103. https://doi.org/10.18093/0869-0189-2012-0-3-97-103
For citation:
Pristupa L.N., Fadeeva A.A. Relationships of asthma and obesity. PULMONOLOGIYA. 2012;(3):97-103. (In Russ.) https://doi.org/10.18093/0869-0189-2012-0-3-97-103
Просмотров: 593
Послать статью по эл. почте 